FDA Class II · Drug · April 29, 2026
Furosemide Tablets recall — Leading Pharma, LLC
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Official ID D-0486-2026 · Official record ↗
⚠ Recall found. Furosemide Tablets is named in 1 official recall in our current data. Details and the official notices are below — act on the remedy in the official notice.
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Official ID D-0486-2026 · Official record ↗
See all Leading Pharma recalls →
Found something wrong or missing? Report a data error.
Compiled from official public-domain CPSC, NHTSA, and FDA data. Sources last checked July 24, 2026 at 1:09 AM UTC.